Secondary outcomes included changes in MDS-UPDRS when on dopamine-based medication, as well as off-and-on state analysis of timed sit-stand-walk tests and scores from a battery of neuropsychological exams
Its incredible when you see the results people are experiencing. * Dual Activation for Total Transformation The MindBody GLP-1 System, combined with an active lifestyle, promotes weight loss, enhances body composition, and fosters a healthier relationship with food
Patients often experience swelling, bruising, firmness, temporary numbness, soreness, and drainage from access points
Nat Med, 2022
Trials show semaglutide users lose about 15% of their body weight, while tirzepatide patients can lose around 21%
We did not include achievement of at least a 5% reduction in body weight as an outcome because all doses of both drugs were superior to placebo in achieving at least a 10% weight reduction